Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries

por Stolbrink, M., Chinouya, M. J., Jayasooriya, S., Nightingale, R., Evans-Hill, L., Allan, K., Allen, H., Balen, J., Beacon, T., Bissell, K., Chakaya, J., Chiang, C-Y., Cohen, M., Devereux, G., El Sony, A., Halpin, D. M. G., Hurst, J. R., Kiprop, C., Lawson, A., Macé, C., Makhanu, A., Makokha, P., Masekela, R., Meme, H., Khoo, E. M., Nantanda, R., Pasternak, S., Perrin, C., Reddel, H., Rylance, S., Schweikert, P., Were, C., Williams, S., Winders, T., Yorgancioglu, A., Marks, G. B., Mortimer, K.
Publicado 2022

A very sneaky bug: perspectives of front-line clinicians on whole-genome sequencing for drug-resistant TB

por Memani, B., Furin, J., Cox, H., Reuter, A.
Publicado 2022

The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia

por Devoid, I., Sillah, A. K., Sutherland, J., Owolabi, O., Ivanova, O., Govathson, C., Hirasen, K., Davies, M., Lönnroth, K., Loum, I., Touray, A., Charlambous, S., Evans, D., Quaife, M.
Publicado 2022

Use of big data on the social determinants of TB to find the “missing millions”

por Biermann, O., Wingfield, T., Thapa, B., Babajide, O., Zeinali, Z., Torres, I., Abdalla, S M, Galea, Sandro
Publicado 2022

Association between chronic obstructive pulmonary disease and biomass smoke in rural areas

por Ramírez-Venegas, A., Montiel-Lopez, F., Pérez Lara-Albisua, J. L., Aranda-Chávez, A., Perea-Gutiérrez, H., Falfán-Valencia, R., Pérez-Rubio, G., Pérez-Padilla, R., Ramírez-Díaz, M., Martínez-Gómez, M. L., Cruz-Vicente, F., Thirión-Romero, I., Sansores, R. H.
Publicado 2022

eHealth in TB clinical management

por Margineanu, I., Louka, C., Akkerman, O., Stienstra, Y., Alffenaar, J-W.
Publicado 2022

Effect of 6-month vs. 8-month regimen on retreatment success for pulmonary TB

por Izudi, J., Sheira, L. A., Bajunirwe, F., McCoy, S. I., Cattamanchi, A.
Publicado 2022

Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB

por Zeng, C., Mitnick, C. D., Hewison, C., Bastard, M., Khan, P., Seung, K. J., Rich, M. L., Atwood, S., Melikyan, N., Morchiladze, N., Khachatryan, N., Khmyz, M., Restrepo, C. G., Salahuddin, N., Kazmi, E., Dahri, A. A., Ahmed, S., Varaine, F., Vilbrun, S. C., Oyewusi, L., Gelin, A., Tintaya, K., Yeraliyeva, L. T., Hamid, S., Khan, U., Huerga, H., Franke, M. F.
Publicado 2023

Sugar and sugar-free liquid formulations of delamanid for patients with rifampicin-resistant TB

por Taneja, R., Nahata, M. C., Scarim, J., Pande, P. G., Scarim, A., Hoddinott, G., Fourie, C. L., Jew, R. K., Schaaf, H. S., Garcia-Prats, A. J., Hesseling, A. C.
Publicado 2023

Isolation and purification of lipoarabinomannan from urine of adults with active TB

por Cantera, J. L., Rashid, A. A., Lillis, L. M., Peck, R. B., Drain, P. K., Shapiro, A. E., Wilson, D. P. K., Pinter, A., Kawasaki, M., Moreau, E., Boyle, D. S.
Publicado 2023

Clinical utility of target-based next-generation sequencing for drug-resistant TB

por Mansoor, H., Hirani, N., Chavan, V., Das, M., Sharma, J., Bharati, M., Oswal, V., Iyer, A., Morales, M., Joshi, A., Ferlazzo, G., Isaakidis, P., Ndlovu, Z., England, K.
Publicado 2023

Co-administration of treatment for drug-resistant TB and hepatitis C

por Olaru, I. D., Beliz Meier, M., Schumacher, S. G., Prodanovic, N., Kitchen, P. J., Mirzayev, F., Denkinger, C. M.
Publicado 2023

Comparison of pharmacokinetics and bioavailability of bedaquiline fumarate, benzoate and maleate in dogs

por Jaw-Tsai, S., Barry, R., Pande, P. G., Taneja, R., Yang, T.
Publicado 2023

Extemporaneously compounded liquid formulations of clofazimine

por Taneja, R., Nahata, M. C., Scarim, J., Pande, P. G., Scarim, A., Hoddinott, G., Fourie, C. L., Jew, R. K., Schaaf, H. S., Hesseling, A. C., Garcia-Prats, A. J.
Publicado 2023

Strategic approach to optimisation of TB contact investigation in Nigeria

por Chukwuogo, O., Odume, B., Ogbudebe, C., Useni, S., Nwokoye, N., Dim, C., Nongo, D., Eneogu, R., Odusote, T., Oyelaran, O., Ubochioma, E., Anyaike, C., Gidado, M.
Publicado 2023

CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities

por Fehr, J., Gunda, R., Siedner, M. J., Hanekom, W., Ndung’u, T., Grant, A., Lippert, C., Wong, E. B.
Publicado 2023

Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus

por Alkabab, Y., Warkentin, J., Cummins, J., Katz, B., Denison, B. M., Bartok, A., Khalil, A., Young, L. R., Timme, E., Peloquin, C. A., Ashkin, D., Houpt, E. R., Heysell, S. K.
Publicado 2023

Co-testing a single sputum specimen for TB and SARS-CoV-2

por Genade, L. P., Kahamba, T., Scott, L., Tempia, S., Walaza, S., David, A., Stevens, W., Hlongwane, K., von Gottberg, A., Du Plessis, M., Kleynhans, J., Cohen, C., Martinson, N. A.
Publicado 2023

Stable, compounded bedaquiline suspensions to support practical implementation of pediatric dosing in the field

por Taneja, R., Nahata, M. C., Scarim, J., Pande, P. G., Scarim, A., Hoddinott, G., Fourie, C. L., Jew, R. K., Schaaf, H. S., Garcia-Prats, A. J., Hesseling, A. C.
Publicado 2023

Continuous cough monitoring: a novel digital biomarker for TB diagnosis and treatment response monitoring

por Huddart, S., Asege, L., Jaganath, D., Golla, M., Dang, H., Lovelina, L., Derendinger, B., Andama, A., Christopher, D. J., Nhung, N. V., Theron, G., Denkinger, C. M., Nahid, P., Cattamanchi, A., Yu, C.
Publicado 2023